Operational Risk Management in OTC Derivatives in Asia
Operational risk relates to losses resulting from inadequate or failed internal processes or external events. It has come into greater focus in the last four to five years among OTC derivatives market participants, particularly in the wake of the financial crisis.
In a new report, Operational Risk Management in OTC Derivatives in Asia, Celent looks at issues Asian markets have had with operational risk. The markets have been making efforts to reduce operational risk, and this practice has generated legal documentation that ensures standard procedures are available for executing transactions. Due to improvements in both technology and regulation, market participants have gradually moved to electronic trade processing. These efforts are likely to be boosted by mandatory use of data repositories and widening use of central clearing.
“Operational risk management has become much more important in the last few years,” says Anshuman Jaswal, Celent Senior Analyst and author of the report. “Attempts by regulators to improve transparency and reduce operational risk will bear fruit only if OTC derivatives market participants have the necessary reporting mechanisms in place. If that occurs, information sharing will become a vital element in their processes.”
This report considers the volumes of OTC derivatives traded on a global basis, as well as the operational performance of the market participants. The report then looks at the various factors and drivers that lead to operational risk and the use of capital requirements to mitigate this risk. The Basel II and III frameworks for operational risk management provide insights on how banks manage this risk. The report concludes with best practices to ensure firms minimize the levels of OTC derivatives operational risk in their organizations.
Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies. Celent publishes reports identifying trends and best practices in financial services technology and conducts consulting engagements for financial institutions looking to use technology to enhance existing business processes or launch new business strategies. With a team of internationally based analysts, Celent is uniquely positioned to offer strategic advice and market insights on a global basis. Celent is a member of the Oliver Wyman Group, which is a wholly-owned subsidiary of Marsh & McLennan Companies [NYSE: MMC].
Tel: +1 212 345 1366
Tel: +44 (0)782 448 3336
Tel.: +81 3 3500 3023
Table of Contents
Operational Risk and the Asian Market
OTC Derivatives Volumes and Processing
Factors Causing Operational Risk
Basel Framework on Operational Risk
Best Practices for Managing Operational Risk
Leveraging Celent’s Expertise
Support for Financial Institutions
Support for Vendors
Related Celent Research